Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Afatinib × CNS × Clear all

Phase

Status

Completed 3 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 12 Gastrointestinal 5 Tumor-Agnostic 3 Sarcoma 1 Head & Neck 1 CNS 1 Breast 1

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 67 Radiotherapy 52 Carboplatin 25 Bevacizumab 22 Cisplatin 19 Radiosurgery 18 Vincristine 17 Etoposide 17 Cyclophosphamide 17 Surgical Procedures, Operative 13 Magnetic Resonance Spectroscopy 13 Chemotherapy, Adjuvant 11 Melphalan 10 Drug Therapy 10 Lomustine 9 Filgrastim 9 Erlotinib Hydrochloride 9 apatinib 8 Radiation 8 Pemetrexed 8 3-Iodobenzylguanidine 8 anlotinib 7 Peripheral Blood Stem Cell Transplantation 7 Methotrexate 7 Irinotecan 7 Thiotepa 6 Isotretinoin 6 Ifosfamide 6 Doxorubicin 6 Carmustine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04158947 2020-05-12

HER2BAT

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Unknown

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡